{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T07:21:30Z","timestamp":1749972090531},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Chang Gung Memorial Hospital, Kaohsiung","award":["CMRPG-8C1321"],"award-info":[{"award-number":["CMRPG-8C1321"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12880-016-0171-7","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T14:06:19Z","timestamp":1483625179000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy"],"prefix":"10.1186","volume":"17","author":[{"given":"Yung-Cheng","family":"Huang","sequence":"first","affiliation":[]},{"given":"Hung-I","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Shun-Chen","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Chien-Chin","family":"Hsu","sequence":"additional","affiliation":[]},{"given":"Nan-Tsing","family":"Chiu","sequence":"additional","affiliation":[]},{"given":"Yu-Ming","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yi-Chun","family":"Chiu","sequence":"additional","affiliation":[]},{"given":"Shau-Hsuan","family":"Li","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"171_CR1","unstructured":"Ferlay J SI, Ervik M. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http:\/\/globocan.iarc.fr\/Default.aspx . Accessed Dec 2013. GLOBOCAN 2012 v10."},{"key":"171_CR2","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","volume":"27","author":"WH Allum","year":"2009","unstructured":"Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062\u20137.","journal-title":"J Clin Oncol"},{"key":"171_CR3","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P Van Hagen","year":"2012","unstructured":"Van Hagen P, Hulshof MC, Van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"key":"171_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semradonc.2006.09.007","volume":"17","author":"JR Siewert","year":"2007","unstructured":"Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol. 2007;17:38\u201344.","journal-title":"Semin Radiat Oncol"},{"key":"171_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/annonc\/mdn622","volume":"20","author":"E Bollschweiler","year":"2009","unstructured":"Bollschweiler E, Metzger R, Drebber U, et al. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol. 2009;20:231\u20138.","journal-title":"Ann Oncol"},{"key":"171_CR6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226\u201334.","journal-title":"Lancet Oncol"},{"key":"171_CR7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086\u201392.","journal-title":"J Clin Oncol"},{"key":"171_CR8","first-page":"84","volume":"5","author":"AA Meluch","year":"1999","unstructured":"Meluch AA, Hainsworth JD, Gray JR, et al. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J Sci Am. 1999;5:84\u201391.","journal-title":"Cancer J Sci Am"},{"key":"171_CR9","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","volume":"23","author":"AC Berger","year":"2005","unstructured":"Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23:4330\u20137.","journal-title":"J Clin Oncol"},{"key":"171_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.athoracsur.2005.01.044","volume":"80","author":"JB Dimick","year":"2005","unstructured":"Dimick JB, Goodney PP, Orringer MB, et al. Specialty training and mortality after esophageal cancer resection. Ann Thorac Surg. 2005;80:282\u20136.","journal-title":"Ann Thorac Surg"},{"key":"171_CR11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jamcollsurg.2007.07.001","volume":"205","author":"RC Connors","year":"2007","unstructured":"Connors RC, Reuben BC, Neumayer LA, et al. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg. 2007;205:735\u201340.","journal-title":"J Am Coll Surg"},{"key":"171_CR12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.athoracsur.2007.10.007","volume":"85","author":"AC Chang","year":"2008","unstructured":"Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008;85:424\u20139.","journal-title":"Ann Thorac Surg"},{"key":"171_CR13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00464-011-1911-y","volume":"26","author":"S Misra","year":"2012","unstructured":"Misra S, Choi M, Livingstone AS, et al. The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc. 2012;26:518\u201322.","journal-title":"Surg Endosc"},{"key":"171_CR14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s11605-013-2189-2","volume":"17","author":"HS Heinzow","year":"2013","unstructured":"Heinzow HS, Seifert H, Tsepetonidis S, et al. Endoscopic ultrasound in staging esophageal cancer after neoadjuvant chemotherapy--results of a multicenter cohort analysis. J Gastrointest Surg. 2013;17:1050\u20137.","journal-title":"J Gastrointest Surg"},{"key":"171_CR15","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","volume":"22","author":"HL Van Westreenen","year":"2004","unstructured":"Van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18\u00a0F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805\u201312.","journal-title":"J Clin Oncol"},{"key":"171_CR16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00259-005-1795-y","volume":"32","author":"R Bar-Shalom","year":"2005","unstructured":"Bar-Shalom R, Guralnik L, Tsalic M, et al. The additional value of PET\/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging. 2005;32:918\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"171_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.athoracsur.2006.03.045","volume":"82","author":"RJ Cerfolio","year":"2006","unstructured":"Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg. 2006;82:391\u20134. discussion 4\u20135.","journal-title":"Ann Thorac Surg"},{"key":"171_CR18","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.athoracsur.2009.02.065","volume":"87","author":"WH Hsu","year":"2009","unstructured":"Hsu WH, Hsu PK, Wang SJ, et al. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg. 2009;87:1564\u20138.","journal-title":"Ann Thorac Surg"},{"key":"171_CR19","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1259\/bjr\/79854022","volume":"85","author":"WQ Zhu","year":"2012","unstructured":"Zhu WQ, Sun X, Xing L, et al. Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification. Br J Radiol. 2012;85:e383\u20137.","journal-title":"Br J Radiol"},{"key":"171_CR20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2967\/jnumed.112.110304","volume":"54","author":"O Manabe","year":"2013","unstructured":"Manabe O, Hattori N, Hirata K, et al. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. J Nucl Med. 2013;54:670\u20136.","journal-title":"J Nucl Med"},{"key":"171_CR21","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.","edition":"7"},{"key":"171_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamasurg.2014.3867","volume":"150","author":"M Kukar","year":"2015","unstructured":"Kukar M, Alnaji RM, Jabi F, et al. Role of Repeat 18\u00a0F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. JAMA Surg. 2015;150:555\u201362.","journal-title":"JAMA Surg"},{"key":"171_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00408-013-9500-6","volume":"191","author":"YT Sim","year":"2013","unstructured":"Sim YT, Goh YG, Dempsey MF, et al. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology. Lung. 2013;191:625\u201332.","journal-title":"Lung"},{"key":"171_CR24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.1998.16.3.1075","volume":"16","author":"VJ Lowe","year":"1998","unstructured":"Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075\u201384.","journal-title":"J Clin Oncol"},{"key":"171_CR25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2005.03.033","volume":"63","author":"SY Song","year":"2005","unstructured":"Song SY, Kim JH, Ryu JS, et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys. 2005;63:1053\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"171_CR26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM, et al. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310\u201320.","journal-title":"AJR Am J Roentgenol"},{"key":"171_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12149-015-1034-y","volume":"30","author":"SY Park","year":"2016","unstructured":"Park SY, Lee SJ, Yoon JK. The prognostic value of total lesion glycolysis via 18\u00a0F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma. Ann Nucl Med. 2016;30:81\u20138.","journal-title":"Ann Nucl Med"},{"key":"171_CR28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.7314\/APJCP.2014.15.3.1369","volume":"15","author":"YM Li","year":"2014","unstructured":"Li YM, Lin Q, Zhao L, et al. Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients. Asian Pac J Cancer Prev. 2014;15:1369\u201373.","journal-title":"Asian Pac J Cancer Prev"},{"key":"171_CR29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cncr.20724","volume":"103","author":"H Kato","year":"2005","unstructured":"Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148\u201356.","journal-title":"Cancer"},{"key":"171_CR30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejcts.2007.01.037","volume":"31","author":"SG Little","year":"2007","unstructured":"Little SG, Rice TW, Bybel B, et al. Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg. 2007;31:791\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"key":"171_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3892\/etm.2012.772","volume":"5","author":"M Sun","year":"2013","unstructured":"Sun M, Li B, Fu Z, et al. Relationship between (18)F-fluorodeoxyglucose uptake in primary lesions and clinicopathological characteristics of esophageal squamous cell carcinoma patients. Exp Ther Med. 2013;5:170\u20134.","journal-title":"Exp Ther Med"},{"key":"171_CR32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2967\/jnumed.114.138974","volume":"55","author":"G Lee","year":"2014","unstructured":"Lee G, I H, Kim SJ, et al. Clinical implication of PET\/MR imaging in preoperative esophageal cancer staging: comparison with PET\/CT, endoscopic ultrasonography, and CT. J Nucl Med. 2014;55:1242\u20137.","journal-title":"J Nucl Med"},{"key":"171_CR33","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s00464-015-4578-y","volume":"30","author":"W Bohle","year":"2016","unstructured":"Bohle W, Kasper M, Zoller WG. Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer. Surg Endosc. 2016;30:2922\u20138.","journal-title":"Surg Endosc"},{"key":"171_CR34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2004.04.046","volume":"78","author":"SG Swisher","year":"2004","unstructured":"Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004;78:1152\u201360. discussion \u221260.","journal-title":"Ann Thorac Surg"},{"key":"171_CR35","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","volume":"24","author":"K Ott","year":"2006","unstructured":"Ott K, Weber WA, Lordick F, et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2006;24:4692\u20138.","journal-title":"J Clin Oncol"},{"key":"171_CR36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ejca.2007.04.001","volume":"43","author":"MK Kim","year":"2007","unstructured":"Kim MK, Ryu JS, Kim SB, et al. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Eur J Cancer. 2007;43:1385\u201391.","journal-title":"Eur J Cancer"},{"key":"171_CR37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1148\/radiol.09091324","volume":"254","author":"RM Kwee","year":"2010","unstructured":"Kwee RM. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18\u00a0F FDG PET: a systematic review. Radiology. 2010;254:707\u201317.","journal-title":"Radiology"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-016-0171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T05:26:58Z","timestamp":1568698018000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-016-0171-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1186\/s12880-016-0171-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"1"}}